Sclerosis multiplex (SM): vizsgálatok itt: Spanyolország
35 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 10.. Ask the study team whether a trial fits you.
- 2. fázisTaking peopleA Pharmacokinetics (PK), Pharmacodynamics (PD), Safety and Tolerability Study of Fenebrutinib in Children and Adolescents With Relapsing Multiple Sclerosis (RMS)
- Where
- Madrid, Seville
- Életkor
- 10 év to 17 év
- People
- 12 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT07161258 · EU 2024-519800-28-00 - 3. fázisTaking peopleA Study of Orelabrutinib in Patients With Secondary Progressive Multiple Sclerosis
- Where
- A Coruña, Badalona, Barakaldo, Barcelona, Castilleja De La Cuesta, Madrid, Majadahonda, Malaga, Murcia, Salt, Sevilla, Valencia, Vigo
- Életkor
- 18 év to 60 év
- People
- 990 worldwide
- Run by
- Zenas BioPharma (USA), LLC
See details and how to joinNCT07299019 · EU 2025-524322-18-00 - 3. fázisTaking peopleA Study of Orelabrutinib in Patients With Primary Progressive Multiple Sclerosis
- Where
- A Coruña, Badalona, Barakaldo, Castilleja De La Cuesta, Madrid, Majadahonda, Murcia, Salt, Vigo
- Életkor
- 18 év to 60 év
- People
- 705 worldwide
- Run by
- Zenas BioPharma (USA), LLC
See details and how to joinNCT07067463 · EU 2025-524316-11-00 - 3. fázisTaking peopleEfficacy and safety study of frexalimab (SAR441344) in adults with relapsing forms of multiple sclerosis
- Where
- Barcelona, Córdoba, Las Palmas De Gran Canaria, Madrid, Málaga, Murcia, Pozuelo de Alarcón, Sevilla, Valladolid
- Életkor
- 18 év to 64 év
- People
- 386 worldwide
- Run by
- Sanofi-Aventis Recherche & Developpement
See details and how to join2023-504358-36-00 · EU 2023-504358-36-00 - 3. fázisTaking peopleEfficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis.
- Where
- Barcelona, Córdoba, Madrid, Majadahonda, Málaga, Murcia, Salt, Sevilla, Valencia
- Életkor
- 40 év to 70 év
- People
- 400 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT06846281 · EU 2023-509275-17-00 - No phaseTaking peopleVirtual Reality - Gamma Sensory Stimulation for Improving Fatigue in People With Multiple Sclerosis
- Where
- Barcelona
- Életkor
- 18 év to 65 év
- People
- 30
- Run by
- Clarity Health Technologies, Inc
See details and how to joinNCT07310862 - 3. fázisTaking peopleA Randomized, Double-blind, Study to Demonstrate Pharmacokinetic Similarity, and Evaluate Safety, Immunogenicity, Pharmacodynamics and Clinical Effects between ABP 692 and Ocrevus® (Ocrelizumab) in Subjects with Relapsing-remitting Multiple Sclerosis
- Where
- Alcorcón, Barcelona, Castilleja De La Cuesta, Denia, Madrid, Malaga, Málaga, Salt, Sevilla, Valencia, Vigo
- Életkor
- 18 év to 64 év
- People
- 125 worldwide
- Run by
- Amgen Inc.
See details and how to join2024-512914-16-00 · EU 2024-512914-16-00 - 1. fázisTaking peopleObe-cel in Refractory Progressive Forms of Multiple Sclerosis
- Where
- Barcelona, Valencia
- Életkor
- 18 év to 60 év
- People
- 24 worldwide
- Run by
- Autolus Limited
See details and how to joinNCT07139743 · EU 2024-519552-93-00 - 3. fázisTaking peopleA Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis
- Where
- Albacete, Alicante, Barakaldo, Barcelona, Castilleja de la Cuesta, El Palmar, Jerez de la Frontera, Las Palmas GC, L'Hospitalet de Llobregat, Lleida, Logroño, Madrid, Málaga, Pozuelo de Alarcón, Salamanca, Seville, Torrejón de Ardoz, Valencia
- Életkor
- 18 év to 65 év
- People
- 1275 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT07225504 - 3. fázisTaking peopleNon-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple Sclerosis
- Where
- Barakaldo, Barcelona, Córdoba, Donostia, Girona, Las Palmas De Gran Canaria, L'hospitalet De Llobregat, Lleida, Madrid, Majadahonda, Málaga, Murcia, Pozuelo de Alarcón, Sevilla, Valencia, Valladolid, Vigo, Zaragoza
- Életkor
- 18 év to 60 év
- People
- 160 worldwide
- Run by
- Sanofi
See details and how to joinNCT07325292 · EU 2026-525688-41-00 - 2. fázisTaking peopleA Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of RO7268489 as Add-on Therapy to Ocrelizumab, in Participants With Progressive Forms of Multiple Sclerosis (MS)
- Where
- Albacete, Barakaldo, Barcelona, L'hospitalet De Llobregat, Lleida, Madrid, Málaga, Murcia, Pozuelo de Alarcón, Salt, Santander, Santiago de Compostela, Sevilla, Valencia, Vigo
- Életkor
- 18 év to 60 év
- People
- 360 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT07282574 · EU 2025-521636-10-00 - No phaseNot yet taking people in SpanyolországInductive Therapeutic Exercise in Multiple Sclerosis
- Where
- Madrid
- Életkor
- 18 év and over
- People
- 30
- Run by
- Fundación San Juan De Dios
See details and how to joinNCT07847853 - 3. fázisTaking peopleEfficacy and safety of ofatumumab and siponimod compared to fingolimod in pediatric patients with multiple sclerosis
- Where
- Barakaldo, Madrid, Oviedo, Sevilla
- Életkor
- Up to 17 év
- People
- 64 worldwide
- Run by
- Novartis Pharma AG
See details and how to join2024-511686-11-00 · EU 2024-511686-11-00 - 3. fázisTaking peopleStudy to Evaluate the Effectiveness and Safety of Ozanimod Compared to Fingolimod in Children and Adolescents With Relapsing Remitting Multiple Sclerosis
- Where
- Esplugues De Llobregat, Sevilla, Valencia, Vigo, Zaragoza
- Életkor
- 10 év to 17 év
- People
- 194 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT06408259 · EU 2022-501332-42-00 - No phaseNot yet taking people in Spanyolország[18F]F-DED PET Imaging of Reactive Astrocytes in Multiple Sclerosis
- Where
- Barcelona
- Életkor
- 18 év to 65 év
- People
- 30
- Run by
- Parc de Salut Mar
See details and how to joinNCT07805473 · EU 2026-525702-35-00 - 2. fázisTaking peopleA Phase 2 Study of Obexelimab in Patients with Relapsing Multiple Sclerosis
- Where
- Madrid, Murcia, Sevilla, Valencia
- Életkor
- 18 év to 64 év
- People
- 93 worldwide
- Run by
- Zenas Biopharma (USA) LLC
See details and how to join2024-512707-40-00 · EU 2024-512707-40-00 - No phaseTaking peoplePregnancy Exposure Registry for Vumerity (Diroximel Fumarate)
- Where
- Madrid
- People
- 908 worldwide
- Run by
- Biogen
See details and how to joinNCT05658497 - No phaseTaking peopleThe Effect of a Probiotic Administration as an add-on Treatment in Multiple Sclerosis
- Where
- Barcelona
- Életkor
- 18 év to 60 év
- People
- 80
- Run by
- Hospital Universitari Vall d'Hebron Research Institute
See details and how to joinNCT07168772 - No phaseNot yet taking people in SpanyolországEffectiveness of a Mindfulness-Based Intervention for Pain Management in Patients With Multiple Sclerosis (MPIMS).
- Where
- Seville
- Életkor
- 18 év to 80 év
- People
- 84
- Run by
- Hospital Universitario Virgen Macarena
See details and how to joinNCT07741864 - No phaseTaking peopleImmersive Virtual Reality and Exercise Programs in Multiple Sclerosis: ExeRVIEM III
- Where
- Pontevedra
- Életkor
- 18 év and over
- People
- 30
- Run by
- University of Vigo
See details and how to joinNCT07738120 - 3. fázisTaking peopleA clinical trial to find out how well LOU064 (remibrutinib) works and how safe it is for people with secondary progressive multiple sclerosis
- Where
- Albacete, Alicante, Barakaldo, Barcelona, Castilleja De La Cuesta, Jerez de la Frontera, Las Palmas De Gran Canaria, L'hospitalet De Llobregat, Lleida, Logroño, Madrid, Málaga, Murcia, Pozuelo de Alarcón, Salamanca, Sevilla, Torrejón de Ardoz, Valencia
- Életkor
- 18 év and over
- People
- 677 worldwide
- Run by
- Novartis Pharma AG
See details and how to join2025-521546-23-00 · EU 2025-521546-23-00 - No phaseTaking peopleMixed Reality for Upper Limb Rehabilitation in People With Multiple Sclerosis (VIRTUALDOMUS)
- Where
- Leganés
- Életkor
- 18 év and over
- People
- 30
- Run by
- Universidad Rey Juan Carlos
See details and how to joinNCT06968676 - 2. fázisNot yet taking people in SpanyolországA Phase IIa Study of Vitamin D3 Tolerogenic Dendritic Cells (tolDC) for Multiple Sclerosis
- Where
- Badalona
- Életkor
- 18 év to 65 év
- People
- 14 worldwide
- Run by
- University Hospital, Antwerp
See details and how to joinNCT07020715 · EU 2025-522040-40-01 - No phaseCsak meghívásosEffectiveness of Home-Based Exercise and Brain Stimulation for Reducing Fatigue in Patients With Multiple Sclerosis
- Where
- A Coruña, Santiago de Compostela, Vigo
- Életkor
- 18 év to 75 év
- People
- 60
- Run by
- Jacobo Formigo
See details and how to joinNCT07567989 - No phaseTaking peopleBlood Flow Restriction for Upper Limb Rehabilitation in People With Multiple Sclerosis. A Randomized Controlled Trial (BFRT-EM)
- Where
- Leganés
- Életkor
- 18 év and over
- People
- 20
- Run by
- Universidad Rey Juan Carlos
See details and how to joinNCT06795230